Symbio
Entry
2023
Hold
3yr
Status
Active
Who owns Symbio?
Symbio is a French ClimateTech company, currently owned by ARCHIMED since 2023. It changed hands in 2019, when ENGIE New Ventures sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYOwnership history
2 ownership periods
Active
ENGIE New VenturesExited 2019
2016 · 2019(3yr) · ENGIE New Ventures Fund · 2014 · VC
Trade Sale · to Michelin
ENGIE New Ventures sold Symbio to Michelin in 2019 after 3 years.
ARCHIMEDActive
2023 · present(3yr) · MED Platform II · 2022 · Buyout
More from MED Platform II
Other portfolio companies in the same fund.
More PE-backed in ClimateTech
Comparable climatetech deals from other GPs.
Questions
Who owns Symbio?
Symbio is currently owned by ARCHIMED, through MED Platform II, since 2023.
When did ARCHIMED acquire Symbio?
ARCHIMED acquired Symbio in 2023.
Who did Symbio sell to?
ENGIE New Ventures sold Symbio to Michelin in 2019 (Trade Sale).
Who has owned Symbio over time?
Symbio has been through 2 private-equity ownership periods: ENGIE New Ventures · via ENGIE New Ventures Fund · 2016–2019 · sold to Michelin · (Trade Sale); ARCHIMED · via MED Platform II · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue